EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy.

Screening for EGFR mutation is a key molecular test for management of lung cancer patients. Outcome of patients with mutation receiving EGFR tyrosine kinase inhibitor is known to be better across different ethnic populations. However, frequency of EGFR mutations and the clinical response in most oth...

Full description

Bibliographic Details
Main Authors: Vanita Noronha, Kumar Prabhash, Abhishek Thavamani, Anuradha Chougule, Nilendu Purandare, Amit Joshi, Rashmi Sharma, Saral Desai, Nirmala Jambekar, Amit Dutt, Rita Mulherkar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3631198?pdf=render